“…In relation to studying the downstream effects of dystrophin deficiency, a holistic systems biological analysis of the complex pathogenesis of DMD would greatly enhance our insights into organ crosstalk and encompass an integrative multi-omics approach. This integromics strategy would ideally consist of genomics [ 440 , 441 , 442 ], transcriptomics [ 443 , 444 , 445 ], top-down proteomics [ 17 , 59 , 60 , 61 ], bottom-up proteomics [ 46 , 107 ], subproteomics [ 108 , 109 , 110 , 213 ], the proteomic evaluation of PTMs [ 117 , 291 , 446 , 447 ], metabolomics [ 448 , 449 ], lipidomics [ 450 , 451 , 452 ], glycomics [ 453 ], immunomics [ 454 ], secretomics [ 218 , 219 , 220 , 221 , 455 ] and high-throughput cytomics [ 158 , 172 , 456 , 457 ], as summarized in Figure 6 .…”